Active ingredient: Polysulfated Glycosaminoglycan (PSGAG)
Form: intramuscular (IM) injection
Adequan® I.M. is FDA-approved for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses. Adequan® IM is available in 5 mL vials, packaged individually or in boxes of 7, or as a 50 mL multi-dose vial (all vials contain 500 mg of PSGAG per 5 mL).